SASTASUNDR

Health X Platform Limited

Health X Platform Limited (SASTASUNDR) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

sastasundar.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-04-29

Stock price
₹282.60
Market cap
897 Cr
Stock P/E
Loss (TTM EPS ₹-6.36)
P/B
1.40
ROE (FY26)
0.2%
ROCE (FY26)
-0.2%
Operating margin (FY26)
-4.5%
Debt / equity (FY26)
0.03

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Health X (Health X Platform, formerly Sastasundar Ventures) supplies medicines and healthcare products to retail pharmacies through its RetailerShakti business and delivers to consumers through SastaSundar, with a base in Kolkata and West Bengal.

Company snapshot

9thBy market cap

Ranked among 10 companies in Healthcare Service Provider.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 99.5% of revenue

SegmentRevenue shareRevenuePBTAssets
Financial Services
0.5%
1 Cr0.96 Cr82 Cr
Healthcare Network
99.5%
280 Cr-28 Cr812 Cr

What we see

Positives
  • ✓Debt-to-equity of 0.03x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Net Interest Income-0.06 Cr-0.07 Cr-0.10 Cr0.09 Cr0.14 Cr0.14 Cr0.17 Cr0.12 Cr0.16 Cr0.03 Cr-0.29 Cr-0.40 Cr
Other income10 Cr20 Cr18 Cr28 Cr22 Cr-12 Cr22 Cr25 Cr6 Cr14 Cr14 Cr13 Cr
Net operating income10 Cr20 Cr18 Cr28 Cr22 Cr-12 Cr22 Cr25 Cr6 Cr14 Cr13 Cr12 Cr
Employee cost13 Cr12 Cr12 Cr11 Cr12 Cr11 Cr16 Cr17 Cr20 Cr22 Cr25 Cr28 Cr
Other expenses22 Cr23 Cr24 Cr19 Cr20 Cr31 Cr29 Cr17 Cr19 Cr19 Cr23 Cr21 Cr
Provisions & contingencies————————————
Depreciation2 Cr2 Cr3 Cr2 Cr1 Cr1 Cr1 Cr1 Cr1 Cr2 Cr2 Cr2 Cr
Profit before tax-15 Cr-2 Cr-8 Cr16 Cr-178 Cr-37 Cr-5 Cr30 Cr-19 Cr0.92 Cr-15 Cr2 Cr
Tax %16.8%-33.4%382.2%-161.9%12.9%-2.1%479.2%11.9%17.2%59.9%12.5%-0.6%
Net profit-12 Cr-3 Cr22 Cr41 Cr-155 Cr-38 Cr18 Cr27 Cr-15 Cr0.37 Cr-13 Cr2 Cr
EPS (₹)₹-2.55₹-0.23₹5.17₹9.79₹-34.40₹-8.47₹4.30₹7.52₹-3.99₹0.35₹-3.51₹0.80

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Net Interest Income———0.42 Cr-0.15 Cr-0.90 Cr-0.18 Cr-0.30 Cr0.54 Cr0.02 CrSign in free for the trailing twelve months
Other income—3 Cr2 Cr3 Cr3 Cr12 Cr24 Cr60 Cr60 Cr58 CrSign in free for the trailing twelve months
Net operating income—3 Cr2 Cr4 Cr3 Cr11 Cr23 Cr60 Cr60 Cr58 CrSign in free for the trailing twelve months
Employee cost—16 Cr23 Cr28 Cr29 Cr44 Cr45 Cr49 Cr50 Cr84 CrSign in free for the trailing twelve months
Other expenses—18 Cr33 Cr45 Cr41 Cr54 Cr78 Cr88 Cr100 Cr79 CrSign in free for the trailing twelve months
Provisions & contingencies——————————Sign in free for the trailing twelve months
Depreciation—6 Cr6 Cr5 Cr4 Cr4 Cr8 Cr9 Cr6 Cr7 CrSign in free for the trailing twelve months
Profit before tax—-12 Cr-43 Cr-58 Cr-16 Cr1,109 Cr-122 Cr-30 Cr-204 Cr-2 CrSign in free for the trailing twelve months
Tax %—-19.2%-2.3%9.4%-4.4%11.8%18.6%119.2%34.4%38.6%Sign in free for the trailing twelve months
Net profit—-12 Cr-38 Cr-52 Cr-17 Cr978 Cr-99 Cr6 Cr-134 Cr-1 CrSign in free for the trailing twelve months
EPS (₹)—₹-3.73₹-12.06₹-12.20₹-3.27₹222.73₹-22.70₹2.79₹-28.66₹0.37Sign in free for the trailing twelve months
Dividend payout %—————0.0%—0.0%——Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr
Reserves158 Cr144 Cr105 Cr178 Cr168 Cr876 Cr722 Cr731 Cr638 Cr609 Cr
Borrowings20 Cr12 Cr—5 Cr10 Cr————22 Cr
Other liabilities41 Cr20 Cr91 Cr64 Cr53 Cr70 Cr212 Cr150 Cr110 Cr148 Cr
Total liabilities251 Cr236 Cr228 Cr316 Cr293 Cr1,278 Cr1,206 Cr1,150 Cr974 Cr936 Cr
Fixed assets (net)65 Cr63 Cr116 Cr60 Cr57 Cr57 Cr68 Cr72 Cr63 Cr78 Cr
CWIP—1 Cr—0.0094 Cr0.08 Cr0.42 Cr0.99 Cr0.35 Cr10 Cr1 Cr
Investments17 Cr46 Cr35 Cr56 Cr43 Cr666 Cr515 Cr679 Cr578 Cr521 Cr
Loans & advances———9 Cr8 Cr10 Cr8 Cr8 Cr9 Cr9 Cr
Inventories24 Cr28 Cr33 Cr77 Cr77 Cr114 Cr181 Cr116 Cr110 Cr145 Cr
Trade receivables19 Cr4 Cr8 Cr15 Cr14 Cr21 Cr35 Cr43 Cr10 Cr8 Cr
Cash & bank34 Cr13 Cr7 Cr17 Cr12 Cr13 Cr32 Cr34 Cr12 Cr30 Cr
Other assets93 Cr81 Cr30 Cr81 Cr81 Cr397 Cr366 Cr199 Cr181 Cr144 Cr
Total assets251 Cr236 Cr228 Cr316 Cr293 Cr1,278 Cr1,206 Cr1,150 Cr974 Cr936 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-2 Cr-49 Cr-30 Cr-90 Cr-31 Cr-331 Cr-104 Cr38 Cr-17 Cr-74 Cr
Cash from investing4 Cr21 Cr-3 Cr-1 Cr21 Cr343 Cr124 Cr-34 Cr-1 Cr171 Cr
Cash from financing5 Cr33 Cr27 Cr103 Cr4 Cr-11 Cr-0.87 Cr-2 Cr-0.44 Cr-80 Cr
Net cash flow7 Cr5 Cr-6 Cr11 Cr-5 Cr0.96 Cr19 Cr2 Cr-19 Cr18 Cr
Free cash flow (OCF − Capex)-4 Cr-55 Cr-33 Cr-93 Cr-31 Cr-336 Cr-132 Cr24 Cr-28 Cr-89 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—-5.5%-29.9%-22.6%-6.4%92.0%-12.2%-3.0%-23.5%-0.2%
ROE %—-5.8%-28.0%-15.8%-4.5%58.7%-7.3%0.9%-10.5%0.2%
Debtor days—91314912121132
Inventory days—5951515412441117941353921620216672306066028
Days payable—1973————————
Cash conversion cycle—3987516712455118031355121632216782306366030
Debt / equity0.110.070.000.020.050.00—0.00—0.03
Current ratio2.223.514.50———————
Net debt / EBITDA———————-6.21——